Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Invested Capital (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Invested Capital data on record, last reported at -$82.3 million in Q3 2025.

  • For Q3 2025, Invested Capital fell 132.75% year-over-year to -$82.3 million; the TTM value through Sep 2025 reached -$82.3 million, down 132.75%, while the annual FY2024 figure was $227.0 million, 12.47% down from the prior year.
  • Invested Capital reached -$82.3 million in Q3 2025 per GOSS's latest filing, down from -$46.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $301.0 million in Q3 2023 and bottomed at -$82.3 million in Q3 2025.
  • Average Invested Capital over 4 years is $137.6 million, with a median of $207.8 million recorded in 2022.
  • Peak YoY movement for Invested Capital: skyrocketed 3032.84% in 2024, then crashed 132.75% in 2025.
  • A 4-year view of Invested Capital shows it stood at $207.8 million in 2022, then grew by 24.82% to $259.4 million in 2023, then decreased by 12.47% to $227.0 million in 2024, then crashed by 136.27% to -$82.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were -$82.3 million in Q3 2025, -$46.1 million in Q2 2025, and -$6.2 million in Q1 2025.